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Background: Coronary atherosclerosis burden as expressed in coronary artery calcium (CAC) might be of value in predicting a declined hyperaemic 
myocardial blood flow (MBF). The aim of this study was therefore to evaluate the relationship between CAC content and hyperaemic MBF in patients 
undergoing hybrid [15O]PET/CT imaging.
Methods: We evaluated 225 (mean age 58 ± 10, 114 men) patients with a low to intermediate likelihood for coronary artery disease (CAD) and 
without a documented history of CAD undergoing vasodilator stress [15O]H2O PET/CT and CAC scoring. The CAC score and hyperaemic MBF were 
analyzed.
Results: 88 of 225 patients (39.1%) had a CAC score (CACS) of zero. 134 of 225 patients (59.6%) had subclinical CAD based on an abnormal 
CACS. Of those with CAC, the CACS was 1-100, 101-399, > or = 400, and > or =1000 in 32.9%, 16.4%, 5.3% and 4.9 % of patients, respectively. 
Global CAC score showed a significant inverse correlation with hyperaemic MBF (r = -0.308, p < 0.001). With increasing CACS, there was a decline 
in hyperaemic MBF on a per-patient basis (3.66 ± 1.33 vs 3.17 ± 0.97 vs 2.60 ± 0.84 vs 2.08 ± 0.66 vs 2.02 ± 0.50, p < 0.001, with total CACS 
= 0, 1-100, 101-399, > or = 400, and > or =1000, respectively). Hyperaemic MBF averaged 3.66 ± 1.33 ml/min/g and 2.84 ± 0.98 ml/min/g in 
subjects with a total CACS = 0 and CAC > 0, respectively (p < 0.001).
Conclusions: In patients with a low to intermediate likelihood risk for CAD, a greater CAC burden is associated with a decreased hyperaemic MBF. 
Further studies are warranted for defining CAC cut-off values for prediction of a diminished hyperaemic MBF.
